ZOLL Facility Receives Medicare DMEPOS Accreditation

Integrates ISO Certification and Accreditation into One System
CHELMSFORD, Mass.--(Business Wire)--
ZOLL Medical Corporation (Nasdaq GS: ZOLL), a manufacturer of resuscitation
devices and related software solutions, announced today that its facility in
Pittsburgh, Pennsylvania that manufacturers and sells the LifeVest® Wearable
Defibrillator, has received Durable Medical Equipment, Prosthetics, Orthotics
and Supplies (DMEPOS) Accreditation from Medicare. This designation, in
combination with its ISO 13485 certification, makes ZOLL`s Pittsburgh facility
one of the few healthcare organization facilities to integrate its Medicare
accreditation and ISO 13485 certification into a single accredited management
system.

The Medicare Improvements for Patients and Providers Act of 2008 (MIPPA)
requires all DMEPOS suppliers to meet quality standards for Medicare
accreditation, which is mandatory to maintain National Supplier Clearinghouse
(NSC) billing privileges. DMEPOS accreditation specifically focuses on standards
for administration, financial management, human resource management, consumer
services, performance management, product safety, and information management.
The accreditation also contains service standards, including intake, delivery
and set-up, training and instruction of the beneficiary and/or their caregiver,
and follow-up service.

"ZOLL continues to demonstrate its commitment to the highest level of business
standards by obtaining the Centers for Medicare and Medicaid Services DMEPOS
Accreditation," said Richard A. Packer, Chairman and Chief Executive Officer of
ZOLL. "We are pleased that our process and management systems have enabled us to
achieve this milestone."

The LifeVest durable medical equipment (DME) business model allows a physician
to protect a specific patient by placing a medical order directly with ZOLL.
From this point, ZOLL manages the process to protect the patient from sudden
cardiac arrest through hospital discharge and recovery at home, including
fitting the LifeVest to the specific patient, educating the patient in the
hospital, managing all of the medical documentation and insurance paperwork, and
being available to address any patient needs once home.

The LifeVest is covered by most health plans in the United States, including
commercial, state, and federal plans. To date, the LifeVest has been prescribed
to more than 18,000 patients. For more information, go to www.zoll.lifecor.com
or call 1-800-543-3267.

About ZOLL Medical Corporation

ZOLL Medical Corporation is committed to developing technologies that help
advance the practice of resuscitation and temperature control therapies for the
treatment of critical care patients. With products for pacing, defibrillation,
circulation, temperature management, and fluid resuscitation, ZOLL provides a
comprehensive set of technologies, including Real CPR Help® and See-Thru CPR®,
which help clinicians, EMS professionals, and lay rescuers resuscitate sudden
cardiac arrest or trauma victims. ZOLL also designs and markets software that
automates the documentation and management of both clinical and non-clinical
information.

ZOLL markets and sells its products in more than 140 countries. The Company has
direct operations, distributor networks, and business partners throughout the
U.S., Canada, Latin America, Europe, the Middle East and Africa, Asia, and
Australia. During 2008 ZOLL marked the 25th anniversary of the Company`s
resuscitation product development. For more information, visit www.zoll.com.

Certain statements contained in this press release, including statements
regarding the future business of the Company, and other statements contained
herein regarding matters that are not historical facts, are "forward-looking"
statements (as defined in the Private Securities Litigation Reform Act of 1995).
Because such statements are subject to risks and uncertainties, actual results
may differ materially from those expressed or implied by such forward-looking
statements. Factors that could cause actual results to differ materially from
those expressed or implied by such forward-looking statements include, but are
not limited to, those factors discussed in the section entitled "Risk Factors"
in the Company's Quarterly Report on Form 10-Q filed with the SEC on August 7,
2009. You should not place undue reliance on the forward-looking statements in
this press release, and the Company disavows any obligation to update or
supplement those statements in the event of any changes in the facts,
circumstances, or expectations that underlie those statements.

Copyright © 2009 ZOLL Medical Corporation. All rights reserved. 269 Mill Road,
Chelmsford, MA 01824-4105. ZOLL, LifeVest, Real CPR Help, and See-Thru CPR are
registered trademarks of ZOLL Medical Corporation. All product names are the
property of their respective owners.

INVESTOR CONTACT:
ZOLL Medical Corporation
A. Ernest Whiton, +1 978-421-9655
Chief Financial Officer
or
MEDIA CONTACT:
ZOLL Medical Corporation
Diane Egan, +1 978-421-9637
degan@zoll.com

Copyright Business Wire 2009